Sabby Management, LLC Aveo Pharmaceuticals, Inc. Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.21 - $7.45 $67,161 - $80,571	-10,815 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.97 - $15.28 $341,943 - $875,192	-57,277 Reduced 84.12%	10,815 $79,000
Q4 2020 Feb 16, 2021	BUY	$5.08 - $6.68 $213,629 - $280,914	42,053 Added 161.5%	68,092 $393,000
Q3 2020 Nov 16, 2020	SELL	$4.16 - $6.26 $254,924 - $383,612	-61,280 Reduced 70.18%	26,039 $155,000
Q2 2020 Aug 14, 2020	SELL	$3.47 - $9.99 $86,180 - $248,111	-24,836 Reduced 22.14%	87,319 $450,000
Q1 2020 May 15, 2020	BUY	$2.6 - $6.9 $291,603 - $773,869	112,155 New	112,155 $406,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.